drugset / Trial / NCT06697899
TGRX-678 Phase I Oral Pharmacokinetic Study
Phase 1
Completed
76 enrolled
Shenzhen TargetRx Co., Ltd.
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
A study evaluating the effects of food intake on the pharmacokinetic (PK) profiles of TGRX-678
Timeline
- Start
- 2024-11-24
- Primary completion
- 2025-01-06
- Completion
- 2025-02-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TGRX-678 | Unknown | 240 mg | Oral |